Intrinsic defects in lymph node stromal cells underpin poor germinal center responses during aging

Alice E. Denton, Alyssa Silva-Cayetano, James Dooley, Danika L. Hill, Edward J Carr, Philippe A. Robert, Michael Meyer‐Hermann, Adrian Liston, Michelle A. LintermanbioRxiv 2020 · DOI

TL;DR

As we age, our immune system's ability to generate long-lasting protective immunity after vaccination declines. This study reveals that a key reason for this is the impaired function of lymph node stromal cells, which are crucial for germinal center formation. Targeting these stromal cells could be a new strategy to improve vaccine efficacy in older individuals.

What Problem Does This Paper Address?

Generating robust and long-lasting immunity after vaccination is a cornerstone of public health, but this ability significantly wanes with age. This decline is particularly evident in the germinal center (GC) response, a critical process in secondary lymphoid organs that produces long-lived antibody-secreting cells. While many factors contributing to immunosenescence have been investigated, the primary cellular defect responsible for impaired GC responses in aging has remained elusive. This paper aims to pinpoint this defect by investigating the role of lymph node stromal cells, which form the structural and functional scaffold for GC formation.

Methods

The researchers employed a multi-pronged approach:

  • In vivo mouse models: They used both young (adult) and aged mice to compare GC and follicular dendritic cell (FDC) responses to immunization. Different mouse strains (Balb/c and C57BL/6) were used to ensure consistency.
  • Flow Cytometry: This technique was used to quantify and characterize different cell populations, including GC B cells, FDCs, and Marginal Reticular Cells (MRCs), by analyzing specific surface markers.
  • RNA Sequencing (RNA-seq): This was used to comprehensively analyze the gene expression profiles of FDCs and MRCs from young and aged mice, both before and after immunization, to understand molecular differences in their responses.
  • Heterochronic Parabiosis: This sophisticated technique involves surgically joining the circulatory systems of young and aged mice. It allows researchers to distinguish between the effects of aging on circulating immune cells and the effects of the aged microenvironment (specifically, the lymph node stroma) on immune responses.
  • Mathematical Modeling (Hyphasma): A computational model was used to simulate the impact of reduced FDC networks on GC size and output, helping to understand the functional consequences of FDC network deficits.
  • Adoptive Transfer: B cells from young mice were transferred into young or aged mice to assess the intrinsic capacity of B cells to form GCs in different microenvironments.

Datasets

Not explicitly detailed as "datasets" in the context of machine learning, but the study generated and analyzed:

  • Gene expression data: From RNA sequencing of purified FDCs and MRCs from adult and aged mice.
  • Flow cytometry data: Quantifying cell populations in lymph nodes of mice under various experimental conditions.
  • Immunohistochemistry data: Visualizing FDC networks within lymph nodes.

Key Insights and Ideas

  • Stromal cells are the bottleneck: The study strongly suggests that the primary defect in aging isn't within the lymphocytes themselves, but rather in the lymph node stromal cells that support them.
  • MRCs are key players: Marginal Reticular Cells (MRCs), a type of stromal cell, appear to be particularly affected by aging. Their impaired response to immunization seems to be the root cause of downstream issues.
  • MRC dysfunction cascades: Poor MRC activation and proliferation lead to reduced FDC network expansion, which in turn limits GC formation and ultimately, antibody production.
  • Microenvironment matters more than cell age: The heterochronic parabiosis experiments revealed that the age of the lymph node microenvironment, rather than the age of the B cells themselves, dictates the GC response. Young B cells struggled to form GCs in an aged environment.
  • A new paradigm for immunosenescence: The findings propose a shift in understanding immunosenescence, highlighting the critical role of stromal cell dysfunction as a primary driver of impaired GC responses in aging.

Key Results

  • Aged mice showed significantly reduced GC B cell responses and FDC network expansion following immunization compared to young mice, across different genetic backgrounds.
  • RNA sequencing revealed that aged FDCs and MRCs had altered transcriptional responses to immunization, with aged MRCs showing a particularly blunted response.
  • Mathematical modeling demonstrated that a reduced FDC network size directly limits GC output.
  • Heterochronic parabiosis experiments showed that the aged lymph node microenvironment, not the age of the B cells, was the primary determinant of GC response magnitude. Aged mice in parabiosis with young mice still had poor stromal cell expansion.
  • Adoptive transfer experiments indicated that young B cells were impaired in their ability to form GCs within an aged lymph node environment.

Limitations and Future Work

  • FDC identity and function: While the study identifies MRCs as a key precursor to FDCs, the precise mechanisms by which MRCs differentiate into FDCs and how this process is affected by aging require further investigation.
  • Stromal cell heterogeneity: The study focuses on FDCs and MRCs, but lymph nodes contain a diverse array of stromal cell types. Further research could explore the roles of other stromal cell populations in age-related immune decline.
  • Therapeutic targeting: The authors suggest that targeting stromal cells offers a novel avenue for improving vaccine efficacy in older individuals. Future work could focus on identifying specific molecular targets within stromal cells that could be manipulated to restore immune function.
  • Translational relevance: While the findings are significant, further studies are needed to confirm these mechanisms in humans and to develop effective therapeutic strategies.

Summary updated

Abstract

Abstract The failure to generate enduring humoral immunity after vaccination is a hallmark of advancing age. This can be attributed to a reduction in the germinal center response, which generates long-lived antibody-secreting cells that provide protection against (re)infection. Despite intensive investigation into the effect of age on the lymphoid compartment, the primary cellular defect that causes impaired germinal centers in aging has not been identified. Herein we demonstrate that aging reduces the capacity of germinal center-associated stromal cells to respond to vaccination. Heterochronic parabiosis and mathematical modeling demonstrate that a poor stromal cell response limits the size of the germinal center. This study reveals that age-associated defects in stromal cells are a significant barrier to efficacious vaccine responses in older individuals.
BibTeX
@misc{denton2020intrinsic,
  author = {Alice E. Denton and Alyssa Silva-Cayetano and James Dooley and Danika L. Hill and Edward J Carr and Philippe A. Robert and Michael Meyer‐Hermann and Adrian Liston and Michelle A. Linterman},
  title = {{Intrinsic defects in lymph node stromal cells underpin poor germinal center responses during aging}},
  year = {2020},
  doi = {10.1101/2020.05.07.082255},
  howpublished = {bioRxiv},
}
Figure